FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philippa Musoke

Research Profile

Chemicals & Drugs

Disorders

Geographic Areas

Uganda

Living Beings

Physiology

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Richard Katuramu; Adeodata Kekitiinwa; Peter Mugyenyi; Paula Munderi; Victor Musiime; Philippa Musoke; Patricia Nahirya-Ntege; Bethany Naidoo-James; Kusum Nathoo; Andrew J Prendergast; Margaret Thomason; Constance Tumusiime; Tichaona Vhembo; A Sarah Walker; Sabrina Bakeera-Kitaka; Mutsa Bwakura-Dangarembizi; Adrian Cook; Jane Crawley; Diana M Gibb
Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
Peter K Mudiope; Robinah Mulira; Zikulah Namukwaya; Louis Nyende; Deo Wabwire; Danstan Bagenda; Sawsan Elbireer; Mary Glenn Fowler; Soyeon Kim; Mike Mubiru; Philippa Musoke
Long-term clinical and immunologic outcomes of HIV-infected women with and without previous exposure to nevirapine.
Vincent J Tukei; Alice R Asiimwe; Sabrina Bakeera-Kitaka; Israel Kalyesubula; Albert Maganda; Daniella Migisha; Miriam Murungi; Philippa Musoke; Adeodata Kekitiinwa
Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philippa Musoke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard Katuramu; Adeodata Kekitiinwa; Peter Mugyenyi; Paula Munderi; Victor Musiime; Philippa Musoke; Patricia Nahirya-Ntege; Bethany Naidoo-James; Kusum Nathoo; Andrew J Prendergast; Margaret Thomason; Constance Tumusiime; Tichaona Vhembo; A Sarah Walker; Sabrina Bakeera-Kitaka; Mutsa Bwakura-Dangarembizi; Adrian Cook; Jane Crawley; Diana M Gibb
Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
Lancet 2013;381(9875):1391-403.
2013: Peter K Mudiope; Robinah Mulira; Zikulah Namukwaya; Louis Nyende; Deo Wabwire; Danstan Bagenda; Sawsan Elbireer; Mary Glenn Fowler; Soyeon Kim; Mike Mubiru; Philippa Musoke
Long-term clinical and immunologic outcomes of HIV-infected women with and without previous exposure to nevirapine.
Tropical medicine & international health : TM & IH 2013;18(3):344-51.
2013: Vincent J Tukei; Alice R Asiimwe; Sabrina Bakeera-Kitaka; Israel Kalyesubula; Albert Maganda; Daniella Migisha; Miriam Murungi; Philippa Musoke; Adeodata Kekitiinwa
Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.
BMC pediatrics 2013;13():42.
2013: Moorine Penninah Sekadde; Willy Ssengooba; Eric Wobudeya; Sabrina Bakeera-Kitaka; Moses L Joloba; Harriet Kisembo; Philippa Musoke
Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study.
BMC infectious diseases 2013;13():133.
2013: Michael G Hudgens; J Brooks Jackson; Denise J Jamieson; Athena P Kourtis; Newton Kumwenda; Hana Lee; Lynne M Mofenson; Philippa Musoke; Saad Omer; ANDREA RUFF; Taha E Taha; Allan Taylor; Michael C Thigpen; Abubaker Bedri; Robert Bollinger; Charles Chasela; Nikhil Gupte; Charles van der Horst
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(1):131-9.
2012: Maria M James; Micheal Mubiru; Philippa Musoke; William I Towler; Lei Wang; ALLISON AGWU; Danstan Bagenda; Linda Barlow-Mosha; Matthew M Cousins; Deborah Donnell; Jessica M Fogel; Susan H Eshleman
Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children.
The Pediatric infectious disease journal 2012;31(11):e222-8.
2012: Vincent J Tukei; Albert Maganda; Philippa Musoke; Isaac Sebuliba; Alice Asiimwe; Rita Atugonza; Sabrina Bakeera-Kitaka; Israel Kalyesubula; Addy Kekitiinwa
Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda.
Journal of acquired immune deficiency syndromes (1999) 2012;59(3):274-80.
2012: Hoosen M Coovadia; Susan H Eshleman; Wafaie Fawzi; Mary Glenn Fowler; Kathleen George; Laura A Guay; Roderick Kisenge; Diana J Lynn; Yvonne Maldonado; Karim Manji; Lynne M Mofenson; Dhayendre Moodley; Lindiwe Msweli; Philippa Musoke; Anthony Mwatha; Clemensia Nakabiito; Paul Richardson; Lynda Stranix-Chibanda; Sheryl Zwerski; Philip Andrew; Elizabeth R Brown; Vani Chetty; Tsungai Chipato
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
Lancet 2012;379(9812):221-8.
2012: Willy Ssengooba; Suzanne Verver; James Waako; A Wajja; Benon B Asiimwe; Eric Bugumirwa; David P Kateete; Harriet Mayanja-Kizza; Gerald Mboowa; Francis Mumbowa; Philippa Musoke; Germine Nakayita; Carolyn Namaganda; Maria Nassolo; Moses L Joloba
An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda.
Tuberculosis research and treatment 2012;2012():970203.
2011: Carolyne Onyango-Makumbi; Britta Wahren; Hans Wigzell; Sheryl Zwerski; Gretchen Antelman; Lars Falksveden; Mary Glenn Fowler; Laura A Guay; Francis Mmiro; Lawrence H Moulton; Michael Mubiru; Philippa Musoke; Clemensia Nakabiito; Saad Omer; J Brooks Jackson
Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).
Journal of acquired immune deficiency syndromes (1999) 2011;58(4):399-407.
2011: Maria M James; Lei Wang; Philippa Musoke; Deborah Donnell; Joshua Fogel; William I Towler; Leila Khaki; Clemensia Nakabiito; J Brooks Jackson; Susan H Eshleman
Association of HIV diversity and survival in HIV-infected Ugandan infants.
PloS one 2011;6(4):e18642.
2011: Peace D Imani; Philippa Musoke; Justus S Byarugaba; James K Tumwine
Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study.
BMC pediatrics 2011;11():5.
2011: Zikulah Namukwaya; Peter Mudiope; Addy Kekitiinwa; Philippa Musoke; Joyce Matovu; Sarah Kayma; William Salmond; Edward Bitarakwate; Michael Mubiru; Albert Maganda; Moses Galla; Josaphat K Byamugisha; Mary Glenn Fowler
The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
Journal of acquired immune deficiency syndromes (1999) 2011;56(1):69-75.
2010: Jessica D Church; Wei Huang; Anthony Mwatha; Philippa Musoke; J Brooks Jackson; Danstan Bagenda; Saad Omer; Deborah Donnell; Clemensia Nakabiito; Chineta Eure; Laura A Guay; Allan Taylor; Paul M Bakaki; Flavia Matovu; Michelle McConnell; Mary Glenn Fowler; Susan H Eshleman
Analysis of HIV tropism in Ugandan infants.
Current HIV research 2010;8(7):498-503.
2010: William I Towler; Maria M James; Stuart C Ray; Lei Wang; Deborah Donnell; Anthony Mwatha; Laura A Guay; Clemensia Nakabiito; Philippa Musoke; J Brooks Jackson; Susan H Eshleman
Analysis of HIV diversity using a high-resolution melting assay.
AIDS research and human retroviruses 2010;26(8):913-8.
2010: William I Towler; Linda Barlow-Mosha; Jessica D Church; Danstan Bagenda; Patrick Ajuna; Micheal Mubiru; Philippa Musoke; Susan H Eshleman
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.
AIDS research and human retroviruses 2010;26(5):563-8.
2010: Oliver Laeyendecker; Jessica D Church; Amy E Oliver; Anthony Mwatha; S Michele Owen; Deborah Donnell; Ron Brookmeyer; Philippa Musoke; J Brooks Jackson; Laura A Guay; Clemesia Nakabiito; Thomas C Quinn; Susan H Eshleman
Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.
PloS one 2010;5(10):e13259.
2009: Jessica D Church; Wei Huang; Neil Parkin; Natalia Marlowe; Laura A Guay; Saad Omer; Philippa Musoke; J Brooks Jackson; Susan H Eshleman
Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.
AIDS research and human retroviruses 2009;25(7):657-63.
2009: Jessica D Church; Anthony Mwatha; Danstan Bagenda; Saad Omer; Deborah Donnell; Philippa Musoke; Clemensia Nakabiito; Chineta Eure; Paul M Bakaki; Flavia Matovu; Michael C Thigpen; Laura A Guay; Michelle McConnell; Mary Glenn Fowler; J Brooks Jackson; Susan H Eshleman
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
AIDS research and human retroviruses 2009;25(7):673-7.
2008: Jessica D Church; Saad Omer; Laura A Guay; Wei Huang; Jessica Lidstrom; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Susan H Eshleman
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
The Journal of infectious diseases 2008;198(7):1075-82.
2008: Sandra J Bliss; Katherine L O'Brien; Edward janoff; Mark F Cotton; Philippa Musoke; Hoosen Coovadia; Orin S Levine
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease.
The Lancet infectious diseases 2008;8(1):67-80.
2007: Victoria B Chou; Saad Omer; Hamidah Hussain; Christine Mugasha; Maria Musisi; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Laura A Guay
The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing.
Journal of acquired immune deficiency syndromes (1999) 2007;46(4):426-32.
2007: Tamara Flys; Anthony Mwatha; Laura A Guay; Clemensia Nakabiito; Deborah Donnell; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Susan H Eshleman
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
AIDS (London, England) 2007;21(15):2077-82.
2007: Wei Huang; Susan H Eshleman; Jonathan Toma; Signe Fransen; Eric Stawiski; Ellen Paxinos; Jeannette M Whitcomb; Alicia M Young; Deborah Donnell; Francis Mmiro; Philippa Musoke; Laura A Guay; J Brooks Jackson; Neil Parkin; Christos J Petropoulos
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
Journal of virology 2007;81(15):7885-93.
2007: Jessica D Church; Sarah E Hudelson; Laura A Guay; Shu Chen; Donald R Hoover; Neil Parkin; Susan A Fiscus; Francis Mmiro; Philippa Musoke; Newton Kumwenda; J Brooks Jackson; Taha E Taha; Susan H Eshleman
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
AIDS research and human retroviruses 2007;23(6):764-8.
2007: Nicolette Nabukeera-Barungi; Israel Kalyesubula; Addy Kekitiinwa; Jayne Byakika-Tusiime; Philippa Musoke
Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala.
Annals of tropical paediatrics 2007;27(2):123-31.
2007: Tamara Flys; Deborah Donnell; Anthony Mwatha; Clemensia Nakabiito; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Laura A Guay; Susan H Eshleman
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
The Journal of infectious diseases 2007;195(5):711-5.
2006: Esther Babirekere-Iriso; Philippa Musoke; Addy Kekitiinwa
Bacteraemia in severely malnourished children in an HIV-endemic setting.
Annals of tropical paediatrics 2006;26(4):319-28.
2006: Tamara Flys; Shu Chen; Dana C Jones; Donald R Hoover; Jessica D Church; Susan A Fiscus; Anthony Mwatha; Laura A Guay; Francis Mmiro; Philippa Musoke; Newton Kumwenda; Taha E Taha; J Brooks Jackson; Susan H Eshleman
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
Journal of acquired immune deficiency syndromes (1999) 2006;42(5):610-3.
2006: Susan H Eshleman; Jessica D Church; Shu Chen; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; Newton Kumwenda; J Brooks Jackson; Taha E Taha; Donald R Hoover
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):518-21.
2006: J Brooks Jackson; Teresa Parsons; Philippa Musoke; Clemensia Nakabiito; Deborah Donnell; Thomas Fleming; Mark Mirochnick; Lynne Mofenson; Mary Glenn Fowler; Francis Mmiro; Laura A Guay
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
AIDS (London, England) 2006;20(2):217-22.
2005: Susan H Eshleman; Donald R Hoover; Shu Chen; Sarah E Hudelson; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Newton Kumwenda; Taha E Taha
Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.
AIDS (London, England) 2005;19(18):2167-9.
2005: Susan H Eshleman; Laura A Guay; Jing Wang; Anthony Mwatha; Elizabeth R Brown; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.
Journal of acquired immune deficiency syndromes (1999) 2005;40(1):24-9.
2005: Susan H Eshleman; Laura A Guay; Anthony Mwatha; Elizabeth Brown; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012.
Journal of acquired immune deficiency syndromes (1999) 2005;39(5):593-7.
2005: Susan H Eshleman; Donald R Hoover; Shu Chen; Sarah E Hudelson; Laura A Guay; Anthony Mwatha; Susan A Fiscus; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Newton Kumwenda; Taha E Taha
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
The Journal of infectious diseases 2005;192(1):30-6.
2005: Tamara Flys; Dwight V Nissley; Cassidy W Claasen; Dana Jones; Chanjuan Shi; Laura A Guay; Philippa Musoke; Francis Mmiro; Jeffrey N Strathern; J Brooks Jackson; James R Eshleman; Susan H Eshleman
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.
The Journal of infectious diseases 2005;192(1):24-9.
2005: Dana Jones; Neil Parkin; Sarah E Hudelson; Laura A Guay; Philippa Musoke; Francis Mmiro; J Brooks Jackson; Susan H Eshleman
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
AIDS research and human retroviruses 2005;21(4):319-24.
2005: Tim R Cressey; Gonzague Jourdain; Marc Lallemant; Suparat Kunkeaw; J Brooks Jackson; Philippa Musoke; Edmund V Capparelli; Mark Mirochnick
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2005;38(3):283-8.
2004: Susan H Eshleman; Laura A Guay; Anthony Mwatha; Shawn P Cunningham; Elizabeth R Brown; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
AIDS research and human retroviruses 2004;20(6):595-9.
2004: Susan H Eshleman; Laura A Guay; Anthony Mwatha; Elizabeth R Brown; Shawn P Cunningham; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).
Journal of acquired immune deficiency syndromes (1999) 2004;35(2):126-30.
2003: J Brooks Jackson; Philippa Musoke; Thomas Fleming; Laura A Guay; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; Joseph Sherman; Paul M Bakaki; Maxensia Owor; Constance Ducar; Martina Deseyve; Anthony Mwatha; Lynda Emel; Corey Duefield; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; Maria Gigliotti; Dorothy Bray; Francis Mmiro
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Lancet 2003;362(9387):859-68.
2002: Susan H Eshleman; Laura A Guay; Thomas Fleming; Anthony Mwatha; Martin R Mracna; Graziella Becker-Pergola; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).
Journal of acquired immune deficiency syndromes (1999) 2002;31(3):327-30.
2002: Laura A Guay; Philippa Musoke; David L Hom; Clemensia Nakabiito; Danstan Bagenda; Courtney V Fletcher; Lawrence H Marum; Mary Glenn Fowler; Lars G Falksveden; Britta Wahren; Peter Kataaha; Hans Wigzell; Francis Mmiro; J Brooks Jackson
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda.
AIDS (London, England) 2002;16(10):1391-400.
2001: Susan H Eshleman; Martin R Mracna; Laura A Guay; Martina Deseyve; S Cunningham; Mark Mirochnick; Philippa Musoke; Thomas Fleming; M Glenn Fowler; Lynne M Mofenson; Francis Mmiro; J Brooks Jackson
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
AIDS (London, England) 2001;15(15):1951-7.
2001: Susan H Eshleman; Graziella Becker-Pergola; Martina Deseyve; Laura A Guay; Martin R Mracna; Thomas Fleming; S Cunningham; Philippa Musoke; Francis Mmiro; J Brooks Jackson
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
The Journal of infectious diseases 2001;184(7):914-7.
2000: Elliot Marseille; James G Kahn; Francis Mmiro; Laura A Guay; Philippa Musoke; Mary Glenn Fowler; J Brooks Jackson
The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Annals of the New York Academy of Sciences 2000;918():53-6.
2000: J Brooks Jackson; Graziella Becker-Pergola; Laura A Guay; Philippa Musoke; Martin R Mracna; Mary Glenn Fowler; Lynne M Mofenson; Mark Mirochnick; Francis Mmiro; Susan H Eshleman
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
AIDS (London, England) 2000;14(11):F111-5.
1999: Elliot Marseille; James G Kahn; Francis Mmiro; Laura A Guay; Philippa Musoke; Mary Glenn Fowler; J Brooks Jackson
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Lancet 1999;354(9181):803-9.
1999: Laura A Guay; Philippa Musoke; Thomas Fleming; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; J Sherman; Paul M Bakaki; Constance Ducar; Martina Deseyve; Lynda Emel; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; K Dransfield; D Bray; Francis Mmiro; J Brooks Jackson
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Lancet 1999;354(9181):795-802.
1999: Philippa Musoke; Laura A Guay; Danstan Bagenda; Mark Mirochnick; Clemensia Nakabiito; Thomas Fleming; T Elliott; S Horton; K Dransfield; J W Pav; A Murarka; Melissa Allen; Mary Glenn Fowler; Lynne Mofenson; David L Hom; Francis Mmiro; J Brooks Jackson
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
AIDS (London, England) 1999;13(4):479-86.
1999: Anna Maria Mandalakas; Laura A Guay; Philippa Musoke; C Carroll-Pankhurst; Karen Olness
Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.
Pediatrics 1999;103(2):E21.